A new experimental painkiller, which is non-addictive, has shown promise in Phase 3 clinical studies, suggesting it could be a viable alternative to opioids. The drug, which cuts off pain at the source, has been successful in trials with volunteers and could soon rival popular opioids that are currently dominating the market. However, the introduction of this new medication is not without challenges. Critics point out potential drawbacks, including a possible crackdown on prescription opioids. Additionally, the drug will have to compete with cheap, generic opioids that are already established in the market. The unveiling of this drug coincides with new 'Alternative to Pain' drug legislation, which may prevent preference for existing opioid-containing cheap generics. Researchers, including teams from the University of Texas at Austin, the University of Texas at Dallas, and the University of Miami, have discovered a molecule that reduces hypersensitivity in mice trials related to neuropathic pain, indicating potential for treating chronic pain without opioids.
Experts say the FDA's system for monitoring drugs' side effects after they hit the market is flawed and will require extensive changes. https://t.co/AwSLQeJSOo
New drugs could spell an end to the world’s obesity epidemic. The long-term effects must be carefully studied—but the excitement is justified https://t.co/I03VmC9pVU👇
There may be a solution for treating chronic pain without the use of #Opioids. A team of researchers at @UTAustin, @UT_Dallas and @univmiami have found a molecule that reduces hypersensitivity in trials in #Mice related to neuropathic pain. @PNASNews https://t.co/jDKWZD03ef
Developing a competitive painkiller was the hard part. But now comes the even harder one -- cracking a market dominated by cheap, generic opioids: https://t.co/4aDJHdLtiU
What a coincidence! A new non-opioid pain drug unveils key Phase 3 data suggesting near-equivalence to opioids... and new "Alternative to Pain" drug legislation appears preventing preference for existing opioid-containing cheap generics. Just random. https://t.co/kRv1Gt1Gc4
A new pain medication has drawbacks and could encourage the disastrous crackdown on prescription opioids. https://t.co/J7CiePz15M
Experimental pain drug may offer alternative to opioids for acute pain, study suggests https://t.co/aGtHdhst6Q
'Blockbuster' experimental drug cuts off pain at the source and isn't addictive - so could it solve the opioid epidemic? https://t.co/Gwh2F9FGFw https://t.co/MV6ZYW4HaF
A new painkiller, which promises to not be addictive, worked well in study volunteers. It could soon rival popular opioids. https://t.co/6RDuiRyXRZ https://t.co/6RDuiRyXRZ